Compare BioNTech SE - ADR (BNTX) vs Colgate-Palmolive Company (CL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Colgate-Palmolive Company — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Colgate-Palmolive Company trades at $92.31 (market cap $74.26B). The key difference: Colgate-Palmolive Company is far larger — about 3.2× BioNTech SE - ADR's market cap, and Colgate-Palmolive Company pays a 2.28% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CL | |
|---|---|---|
Market Cap | $23.31B | $74.26B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $99.14 |
52-Week Low | $83.89 | $74.98 |
Enterprise Value | $6.60B | $80.74B |
Dividend Yield | — | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →
